share_log

Inhibikase Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-FiveT Investment Management Ltd(4.12%),FiveT Capital AG(4.12%)

Inhibikase Therapeutics | SC 13D:超過5%持股股東披露文件-FiveT Investment Management Ltd(4.12%),FiveT Capital AG(4.12%)

2023/01/31 11:59
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息